Exclusive event on using adeno-associated virus (AAV) vectors in gene therapy
Drug Discovery World
JULY 5, 2023
This webinar will help you understand the AAV workflow, from upstream methods for AAV production and validation to downstream analysis of the packaged product for enhanced therapeutic development. AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers.
Let's personalize your content